DK0391374T3 - Fremgangsmåde til fremstilling af farmaceutiske præparater med høj stabilitet indeholdende bromocriptin, samt hertil svarende produkter - Google Patents

Fremgangsmåde til fremstilling af farmaceutiske præparater med høj stabilitet indeholdende bromocriptin, samt hertil svarende produkter

Info

Publication number
DK0391374T3
DK0391374T3 DK90106403.0T DK90106403T DK0391374T3 DK 0391374 T3 DK0391374 T3 DK 0391374T3 DK 90106403 T DK90106403 T DK 90106403T DK 0391374 T3 DK0391374 T3 DK 0391374T3
Authority
DK
Denmark
Prior art keywords
preparation
high stability
pharmaceutical preparations
preparations containing
corresponding products
Prior art date
Application number
DK90106403.0T
Other languages
Danish (da)
English (en)
Inventor
Luigi Moro
Achille Fiori
Alberto Natali
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Application granted granted Critical
Publication of DK0391374T3 publication Critical patent/DK0391374T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK90106403.0T 1989-04-07 1990-04-04 Fremgangsmåde til fremstilling af farmaceutiske præparater med høj stabilitet indeholdende bromocriptin, samt hertil svarende produkter DK0391374T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8920063A IT1235053B (it) 1989-04-07 1989-04-07 Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.

Publications (1)

Publication Number Publication Date
DK0391374T3 true DK0391374T3 (da) 1995-04-24

Family

ID=11163518

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90106403.0T DK0391374T3 (da) 1989-04-07 1990-04-04 Fremgangsmåde til fremstilling af farmaceutiske præparater med høj stabilitet indeholdende bromocriptin, samt hertil svarende produkter

Country Status (9)

Country Link
US (1) US5066495A (fr)
EP (1) EP0391374B1 (fr)
AT (1) ATE114968T1 (fr)
DD (1) DD293961B5 (fr)
DE (2) DE69014691T2 (fr)
DK (1) DK0391374T3 (fr)
ES (1) ES2029776T3 (fr)
GR (1) GR900300172T1 (fr)
IT (1) IT1235053B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2030174C (fr) * 1990-01-10 1996-12-24 Anthony H. Cincotta Procede pour la reduction a long terme des reserves lipidiques, de l'insulinoresistance, de l'hyperinsulinemie et de l'hypoglycemie chez les vertebres
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
SI9700186B (sl) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US6129931A (en) * 1998-09-03 2000-10-10 Isp Investments Inc. Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
WO2003053292A1 (fr) * 2001-12-20 2003-07-03 Femmepharma, Inc. Administration de medicaments par voie vaginale
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
AU2007216882B2 (en) * 2003-01-02 2010-03-11 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatment of diseases and disorders of the breast
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
MXPA05007266A (es) * 2003-01-02 2006-01-17 Femmepharma Holding Co Inc Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
WO2008083158A2 (fr) * 2006-12-26 2008-07-10 Femmepharma Holding Company, Inc. Administration topique de danazol
GB0715628D0 (en) * 2007-08-10 2007-09-19 Generics Uk Ltd Solid valsartan composition
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US8431155B1 (en) * 2012-04-30 2013-04-30 Veroscience Llc Bromocriptine formulations
CN105640901A (zh) * 2014-11-10 2016-06-08 匈牙利吉瑞大药厂 一种利用新型生产工艺制备甲磺酸溴隐亭片的方法及其应用
HRP20211488T1 (hr) 2016-04-20 2022-02-18 Veroscience Llc Sastav i metoda za liječenje metaboličkih poremećaja
AU2018351131B2 (en) 2017-10-18 2024-05-30 Veroscience Llc Improved bromocriptine formulations
CN117323305B (zh) * 2023-11-07 2024-06-07 杭州沐源生物医药科技有限公司 溴隐亭片剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE627516A (fr) * 1962-01-25
US3836618A (en) * 1971-12-23 1974-09-17 American Home Prod Process for the uniform distribution of a drug on a granulated base
NL7314066A (fr) * 1972-10-18 1974-04-22
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4479911A (en) * 1982-01-28 1984-10-30 Sandoz, Inc. Process for preparation of microspheres and modification of release rate of core material
GR79340B (fr) * 1982-07-06 1984-10-22 Sterwin Ag
US4742054A (en) * 1982-11-23 1988-05-03 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions

Also Published As

Publication number Publication date
ES2029776T1 (es) 1992-10-01
DE69014691D1 (de) 1995-01-19
ES2029776T3 (es) 1995-02-01
IT1235053B (it) 1992-06-17
EP0391374A2 (fr) 1990-10-10
DD293961B5 (de) 1994-11-10
US5066495A (en) 1991-11-19
IT8920063A0 (it) 1989-04-07
EP0391374B1 (fr) 1994-12-07
EP0391374A3 (fr) 1992-07-01
DE391374T1 (de) 1991-02-28
ATE114968T1 (de) 1994-12-15
GR900300172T1 (en) 1991-09-27
DE69014691T2 (de) 1995-04-20

Similar Documents

Publication Publication Date Title
DK0391374T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater med høj stabilitet indeholdende bromocriptin, samt hertil svarende produkter
ES2077897T3 (es) Preparados farmaceuticos secos de dosis bajas.
HUT59005A (en) Process for producing transdermal pharmaceutical preparations containing 2-amino-6-(propyl-amino)-4,5,6,7-tetrahydro-benzothiazole
HUT51617A (en) Process for producing oxadiazole derivatives and pharmaceutical preparations containing these compounds as active substance
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
NO885213D0 (no) Stabiliserte legemidler, fremgangsmŸte til deres fremstilling samt stabile legemiddeltilberedninger.
DK108888D0 (da) Farmaceutisk tablet, farmaceutisk granulat og fremgangsmaader til fremstilling af henholdsvis denne tablet og dette granulat
IL95691A0 (en) Thienylcarboxylates of amino alcohols,their preparation and pharmaceutical compositions containing them
NO882075L (no) 9-alfa-hydroksysteroider, deres fremstilling, en fremgangsmaate for fremstilling av de tilsvarende 9(11)-dehydroderivater samt farmasoeytiske preparater inneholdende forbindelsene.
IL91276A0 (en) Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases
NO860867L (no) Materiale som er anvendelig som farmasoeylisk eksipient, samt fremgangsmaate for fremstilling av et slikt.
DK610988D0 (da) Polypeptider, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater der indeholder dem samt anvendelse deraf til fremstilling af et laegemiddel
DK157016C (da) 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconat, laegemidler indeholdende dette samt fremstilling af disse laegemidler
ATE87467T1 (de) Pharmazeutische zubereitung.
ES2021579B3 (es) Capsulas divisibles en piezas
EP0261524A3 (fr) Préparations médicamentaires
PT80961B (en) Process for the preparation of new pharmaceutical compounds containing mixtures of 4,9-dihydro-4-(1-methyl-4-piperydilene)-10h-benzoý4,5¨-cycloheptaý1,2-b¨thyophene-10-one and antiasthmati c xantines as active ingredient
DK11089A (da) 2,5-diazabicyclooe2.2.1aaheptan-forbindelser, deres anvendelse til fremstilling af antiarytmi-laegemidler, farmaceutiske praeparater indeholdende forbindelserne samt forbindelse til anvendelse som udgangsmateriale ved deres fremstilling
FI900017A (fi) Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi
DK0381174T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske præparater
HU886315D0 (en) Process for the production of pharmaceutical preparations for curing hyperlipaemia, containing oxoquinazoline derivatives as active agents
FR2522966B1 (fr) Comprime en forme de gelule, procede et dispositif pour sa preparation
DK239289A (da) Antibioticum, betegnet gallidermin, og syreadditionssalte deraf, farmaceutiske og kosmetiske praeparater indeholdende forbindelserne og fremgangsmaade til forbindelsernes fremstilling
ES8706441A1 (es) Procedimiento para preparar una composicion farmaceutica a base de sulpirida y un progestageno.